dihydropyridine calcium antagonists: data of evidence based medicine and recom-mendations on practical use
Article Quality & Performance Metrics
Readership in this journal
PopularRanked #1 of 98 articles by views in environmental technology
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
The classification of calcium antagonists is presented. There were considered the results of large randomized trials, which were devoted to study of influence of dihydropyridine calcium antagonists on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern recommendations on treatment of arterial hypertension and ischemic heart disease is defined. The clinical importance of differences between various presentations of dihy-dropyridine calcium antagonists is stressed.
| Reference Key |
martsevich2015racionalnadihydropyridine
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;S. Y. Martsevich |
| Journal | environmental technology |
| Year | 2015 |
| DOI |
10.1234/1819-6446-2007-1-55-59
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.